| abstract |
Described herein are compounds that are estrogen receptor modulators of Formula I, and stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, as described herein. With certain substituents and structural features. Also described are pharmaceutical compositions and medicaments comprising the compounds described herein, and such estrogen receptors for treating diseases or conditions that are mediated or dependent on estrogen receptors. This method uses the modulator alone or in combination with other compounds. (I) [Selection figure] None |